Digestive & Intestinal Remedies (Pharmacies) - Austria

  • Austria
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$87.76m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.16%, resulting in a market volume of US$92.97m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$9.78 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Austria is experiencing steady growth due to several factors.

Customer preferences:
Austrian consumers are increasingly seeking natural and herbal remedies for digestive and intestinal issues. They are becoming more conscious of the potential side effects of traditional medications and are opting for alternative options. This has led to a rise in demand for natural digestive and intestinal remedies, such as herbal teas and supplements. Additionally, there is a growing preference for products that are easy to consume and provide quick relief, such as chewable tablets or liquid formulations.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Austria is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are known to improve the balance of gut bacteria, which can help alleviate symptoms of digestive issues such as bloating, gas, and constipation. The demand for probiotics is being driven by the growing awareness of the importance of gut health and the role it plays in overall well-being. As a result, there has been a surge in the availability of probiotic products in pharmacies across Austria. Another trend in the market is the rising demand for over-the-counter (OTC) digestive remedies. OTC products are medications that can be purchased without a prescription. They are convenient for consumers as they can be easily accessed from pharmacies. OTC digestive remedies include antacids, laxatives, and anti-diarrheal medications. The demand for these products is driven by the increasing prevalence of digestive issues such as heartburn, indigestion, and diarrhea. OTC remedies provide quick relief and are often the first choice for consumers seeking immediate relief from these symptoms.

Local special circumstances:
Austria has a high prevalence of digestive issues among its population. This can be attributed to various factors such as dietary habits, stress, and sedentary lifestyles. The consumption of rich and heavy foods, particularly during festive seasons, can lead to digestive discomfort. Additionally, the fast-paced and stressful lifestyles of many Austrians can contribute to digestive problems. These local circumstances have created a significant market for digestive and intestinal remedies in Austria.

Underlying macroeconomic factors:
The growing aging population in Austria is a key macroeconomic factor driving the demand for digestive and intestinal remedies. As people age, they are more prone to digestive issues such as constipation and acid reflux. The elderly population in Austria is increasing, leading to a higher demand for remedies that address these specific concerns. Furthermore, the overall healthcare expenditure in Austria is increasing, which includes spending on over-the-counter medications. The government is investing in healthcare infrastructure and services, making healthcare more accessible to the general population. This has contributed to the growth of the Digestive & Intestinal Remedies market in Austria. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Austria is developing due to customer preferences for natural remedies, the popularity of probiotics, the demand for over-the-counter digestive remedies, local special circumstances such as dietary habits and stress, and underlying macroeconomic factors such as the aging population and increased healthcare expenditure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)